Identification and distribution of 5‐HT3 recognition sites in the rat gastrointestinal tract

No abstract is available for this paper.

• Publication year

  1992

• Venue

  British Journal of Pharmacology

• Publication date

  1992-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1476-5381.1992.tb14396.xPMID 1504752PMCID PMC1907574
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• TWO KINDS OF TRYPTAMINE RECEPTOR

  1997cited by this paper
• Investigation of the 5‐hydroxytryptamine receptor mechanism mediating the short‐circuit current response in rat colon

  1991cited by this paper
• Solubilization of a 5-HT3 binding site from rabbit small bowel muscularis membranes.

  1990cited by this paper
• Synthesis and biochemical evaluation of tritium-labeled 1-methyl-N-(8-methyl-8-azabicyclo[3.2.1]oct-3-yl)-1H-indazole-3-carboxa mide, a useful radioligand for 5HT3 receptors.

  1990cited by this paper
• 5-Hydroxytryptamine: new receptors and novel drugs for gastrointestinal motor disorders.

  1990cited by this paper
• Binding of the 5-HT3 ligand, [3H]GR65630, to rat area postrema, vagus nerve and the brains of several species.

  1989cited by this paper
• Selective and functional 5-hydroxytryptamine3 receptor antagonism by BRL 43694 (granisetron).

  1989cited by this paper
• Association of [3H]zacopride with 5-HT3 binding sites.

  1989cited by this paper
• Identification and Characterisation of 5‐Hydroxytryptamine3 Recognition Sites in Human Brain Tissue

  1989cited by this paper
• [3H]ICS 205-930 labels 5-HT3 recognition sites in membranes of cat and rabbit vagus nerve and superior cervical ganglion

  1989cited by this paper
• Zacopride, a potent 5‐HT3 antagonist

  1988cited by this paper
• Localisation by autoradiography of neuronal 5-HT3 receptors in the mouse CNS.

  1988cited by this paper
• Pharmacological properties of GR38032F, a novel antagonist at 5‐HT3 receptors

  1988cited by this paper
• [3H]Zacopride: Ligand for the Identification of 5‐HT3 Recognition Sites

  1988cited by this paper
• Purification of an endopeptidase from bovine adrenal medulla granules which cleaves in vitro at paired but not at single basic residues.

  1988cited by this paper
• Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding

  1987cited by this paper
• Neuronal involvement in type 1 hypersensitivity reactions in gut epithelia

  1987cited by this paper
• Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine.

  1986cited by this paper
• The pharmacology and function of 5-HT3receptors

  1986cited by this paper
• Pharmacological analysis of 5-hydroxytryptamine actions on guinea-pig ileal mucosa.

  1985cited by this paper
• Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs

  1985cited by this paper
• MDL 72222: a potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors

  1984cited by this paper
• Effect of serotonin treatment on intestinal transport in the rabbit.

  1977cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper

• The Physiological Control of Eating: Signals, Neurons, and Networks.

  2021cites this paper
• Direct modification of the 5‐HT3 receptor current by some anticancer drugs

  2018cites this paper
• Inhibition of native 5-HT3 receptor-evoked contractions in guinea pig and mouse ileum by antimalarial drugs.

  2014cites this paper
• Pulmonary , gastrointestinal and urogenital pharmacology Inhibition of native 5-HT 3 receptor-evoked contractions in guinea pig and mouse ileum by antimalarial drugs

  2014cites this paper
• Expression of serotonin receptors in human lower esophageal sphincter

  2014cites this paper
• Fatty acid sensing in the gut and the hypothalamus: in vivo and in vitro perspectives.

  2014cites this paper
• Subunit‐dependent inhibition and potentiation of 5‐HT3 receptor by the anticancer drug, topotecan

  2013cites this paper
• The Non-Antiemetic Uses of Serotonin 5-HT3 Receptor Antagonists

  2012cites this paper
• Serotonin-type 3 receptors mediate intestinal lipid-induced satiation and Fos-like immunoreactivity in the dorsal hindbrain.

  2007cites this paper
• Dorsal hindbrain 5-HT3 receptors participate in control of meal size and mediate CCK-induced satiation.

  2006cites this paper
• Serotonin-type 3 receptors mediate intestinal Polycose- and glucose-induced suppression of intake.

  2005cites this paper
• CCK and 5-HT act synergistically to suppress food intake through simultaneous activation of CCK-1 and 5-HT3 receptors.

  2005cites this paper
• Animal Models of Drug-Induced Akathisia

  2005cites this paper
• Serotonin ve Gastrointestinal Sistem

  2003cites this paper
• Neuronal location of 5-hydroxytryptamine3 receptor-like immunoreactivity in the rat colon.

  2003cites this paper
• Serotnin Ve Gastrointestinal Sistem

  2003cites this paper
• Intraduodenal serotonin elicits non-propagating spike potentials in the small intestine of the rat.

  2003cites this paper
• Current experience with 5-HT3 receptor antagonists in fibromyalgia.

  2002cites this paper
• Neuropharmacology of 5-HT3 Receptor Ligands

  2000cites this paper
• Regional differences in neurogenic signal transduction pathway of cholera toxin-induced fluid, electrolyte and serotonin accumulation in the porcine jejunum.

  2000cites this paper
• Effect of decreasing afferent vagal activity with ondansetron on symptoms of bulimia nervosa: a randomised, double-blind trial.

  2000cites this paper
• Pharmacological profile of YM-31636, a novel 5-HT3 receptor agonist, in vitro.

  2000cites this paper
• Animal models of acute drug-induced akathisia - a review.

  2000cites this paper
• Expression of the human 5-HT3A receptor using the baculovirus- and Epstein-Barr virus (EBV)-based expression systems

  2000cites this paper
• Immunolabelling of the rat intestinal tract with antibodies specific to the long form of the 5-hydroxytryptamine3 receptor.

  1998cites this paper
• 5‐HT receptor types in the rat ileum longitudinal muscle: focus on 5‐HT2 receptors mediating contraction

  1997cites this paper
• The effect of a 4-mg preoperative intravenous dose of ondansetron in preventing nausea and vomiting after maxillofacial surgery.

  1996cites this paper
• Sensitivity differences to 5-HT and carbachol in subsections of the isolated rat stomach fundus strip: an improved preparation.

  1996cites this paper
• Serotonin--an intestinal secretagogue--receptor subtypes and intracellular mediators.

  1995cites this paper
• Comparison of the Secretory Actions of 5‐Hydroxytryptamine in the Proximal and Distal Colon of the Rat

  1995cites this paper
• Detection of 5-HT3R-A, a 5-HT3 receptor subunit, in submucosal and myenteric ganglia of rat small intestine using in situ hybridization.

  1995cites this paper
• 5-Hydroxytryptamine receptor subtypes: molecular and functional diversity.

  1994cites this paper
• Ondansetron for Prevention of Postoperative Nausea and Vomiting following Minor Oral Surgery: A Double-blind Randomized Study

  1994cites this paper
• 5-Hydroxytryptamine receptor subtypes in vertebrates and invertebrates.

  1994cites this paper
• Synthesis of [11C]dapoxetine.HCl, a serotonin re-uptake inhibitor: biodistribution in rat and preliminary PET imaging in the monkey.

  1994cites this paper
• Gastrointestinal effects of 5-hydroxytryptamine and related drugs.

  1993cites this paper
• Astra Award Lecture. The psychopharmacology of 5-HT3 receptors.

  1992cites this paper